Subtype
Malignant Thymus Neoplasm
CI-CAN-00001185Explore in graph →
80 active trials1 approved drugs1 evidence items
- NCIt
- C4962
Loading cancer entity…
Subtype
CI-CAN-00001185Explore in graph →
Clinical trials
193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (22)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03968315 | An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma | active not recruiting | N/A | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT01787409 | Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency | active not recruiting | N/A | 565 | Mayo ClinicOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT01599559 |
| active not recruiting |
| N/A |
| 540 |
| International Extranodal Lymphoma Study Group (IELSG)OTHER |
| 14 |
| Jan 15, 2026 |
| clinicaltrials |
Data updated 12 days agoSource updated Sep 18, 2026source: clinicaltrials